Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 274

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Machine and deep learning approaches for cancer drug repurposing

Open access
Issa, Naiem T., Stathias, Vasileios, Schürer, Stephan, Dakshanamurthy, Sivanesan·2021·Seminars in Cancer Biology

Abstract

Knowledge of the underpinnings of cancer initiation, progression and metastasis has increased exponentially in recent years. Advanced “omics” coupled with machine learning and artificial intelligence (deep learning) methods have helped elucidate targets and pathways critical to those processes that may be amenable to pharmacologic modulation. However, the current anti-cancer therapeutic armamentarium continues to lag behind. As the cost of developing a new drug remains prohibitively expensive, repurposing of existing approved and investigational drugs is sought after given known safety profiles and reduction in the cost barrier. Notably, successes in oncologic drug repurposing have been infrequent. Computational in-silico strategies have been developed to aid in modeling biological processes to find new disease-relevant targets and discovering novel drug-target and drug-phenotype associations. Machine and deep learning methods have especially enabled leaps in those successes. This review will discuss these methods as they pertain to cancer biology as well as immunomodulation for drug repurposing opportunities in oncologic diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2019.12.011

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 153 references

Cited by

See all 274

Metadata

Authors
Issa, N. T., Stathias, V., Schürer, S., & Dakshanamurthy, S.
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2021-01
Volume
68
Pages
132-142
ISSN
1044-579X (ISSN-L)
OpenAlex
W2998322952
Cited by
274
References
153
FWCI
12.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Machine and deep learning approaches for cancer drug repurposing. https://app.cochat.ai/papers/10.1016/j.semcancer.2019.12.011
The paper
Issa, N. T., Stathias, V., Schürer, S., & Dakshanamurthy, S. (2021). Machine and deep learning approaches for cancer drug repurposing. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2019.12.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.